"The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach./"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
CARMUSTINE/POLIFEPROSAN 20 - IMPLANT
COMMON BRAND NAME(S): Gliadel
USES: This medication is used with brain surgery and radiation to treat a certain type of brain tumor ( malignant glioma). It is also used with surgery to treat a type of malignant glioma (glioblastoma multiforme) that comes back.
Carmustine works by stopping the growth of tumor cells. It helps to kill any leftover tumor cells that are not taken out by the surgery. Polifeprosan 20 works by controlling the release of carmustine into the area where the brain tumor was taken out.
HOW TO USE: This medication is placed by a surgeon during brain surgery into the area where the brain tumor was taken out. The implant will dissolve slowly, releasing the medication to the surrounding area. Follow all your doctor's instructions on what to do before and after surgery.
The number of implants placed is based on the size of the area to cover. The maximum recommended dose is 8 implants placed at each surgery.
Since this drug can be absorbed through the skin, women who are pregnant or who may become pregnant should not handle this medication.
Additional Gliadel Information
Gliadel - User Reviews
Gliadel User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.